TABLE 10

Prevalence of Abnormal HbA1c (n = 7)

First AuthorCountryAges (y)NDefinition of AbnormalSubgroup (eg, M/F)TotalHealthyOverweightClass IClass IIClass IIIPNotesWeight DefinitionsPopulation Info
Skinner US 6–17 NR >5.7%  1.0 0.5 0.3 3.7   <.05   NHANES 2001–2002 
Salvatore US 3–18 101 >5.6    25 40.9 35.7 42.3 .873   Pediatric endocrinology patients 
O’Hara US 3–19 382 >5.7%  17  13 15 18 NS   Stage 3 pediatric weight management program patients 
Michalsky US Mean 17 242 >6.5%  6.1   3.7 [Typo] 4.2 NS  1: BMI 30–50, 2: 50–60, 3: >60 Bariatric surgery patients 
Skinner US 3–19 8579 >5.7%    1.87 3.40 6.38 13.19 <.001   NHANES 1999–2012 
Valery Australia 5–17 158 <6.0%   12    .539   Indigenous youth 
Hadjiyannakis Canada 5–17 847 >5.7%  15   13 15 16 NR   Pediatric weight management program patients 
First AuthorCountryAges (y)NDefinition of AbnormalSubgroup (eg, M/F)TotalHealthyOverweightClass IClass IIClass IIIPNotesWeight DefinitionsPopulation Info
Skinner US 6–17 NR >5.7%  1.0 0.5 0.3 3.7   <.05   NHANES 2001–2002 
Salvatore US 3–18 101 >5.6    25 40.9 35.7 42.3 .873   Pediatric endocrinology patients 
O’Hara US 3–19 382 >5.7%  17  13 15 18 NS   Stage 3 pediatric weight management program patients 
Michalsky US Mean 17 242 >6.5%  6.1   3.7 [Typo] 4.2 NS  1: BMI 30–50, 2: 50–60, 3: >60 Bariatric surgery patients 
Skinner US 3–19 8579 >5.7%    1.87 3.40 6.38 13.19 <.001   NHANES 1999–2012 
Valery Australia 5–17 158 <6.0%   12    .539   Indigenous youth 
Hadjiyannakis Canada 5–17 847 >5.7%  15   13 15 16 NR   Pediatric weight management program patients 

NR, not reported; NS, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal